Melexis Balance Sheet Health
Financial Health criteria checks 5/6
Melexis has a total shareholder equity of €604.9M and total debt of €187.6M, which brings its debt-to-equity ratio to 31%. Its total assets and total liabilities are €897.1M and €292.1M respectively. Melexis's EBIT is €253.8M making its interest coverage ratio 41.8. It has cash and short-term investments of €34.7M.
Key information
31.0%
Debt to equity ratio
€187.61m
Debt
Interest coverage ratio | 41.8x |
Cash | €34.69m |
Equity | €604.95m |
Total liabilities | €292.11m |
Total assets | €897.06m |
Recent financial health updates
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well
Oct 31Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly
May 22Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Recent updates
These 4 Measures Indicate That Melexis (EBR:MELE) Is Using Debt Reasonably Well
Oct 31Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 11Should You Think About Buying Melexis NV (EBR:MELE) Now?
Oct 01Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Aug 31There's Reason For Concern Over Melexis NV's (EBR:MELE) Price
Aug 19Earnings Update: Melexis NV (EBR:MELE) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Aug 02A Look At The Fair Value Of Melexis NV (EBR:MELE)
Jul 04Is There Now An Opportunity In Melexis NV (EBR:MELE)?
Jun 20Melexis (EBR:MELE) Knows How To Allocate Capital
Jun 07Melexis (EBR:MELE) Seems To Use Debt Quite Sensibly
May 22Shareholders Will Probably Be Cautious Of Increasing Melexis NV's (EBR:MELE) CEO Compensation At The Moment
May 08Calculating The Fair Value Of Melexis NV (EBR:MELE)
Mar 27At €78.60, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Mar 14Many Would Be Envious Of Melexis' (EBR:MELE) Excellent Returns On Capital
Feb 28Melexis' (EBR:MELE) Solid Earnings May Rest On Weak Foundations
Feb 15Melexis (EBR:MELE) Has A Pretty Healthy Balance Sheet
Jan 02What Does Melexis NV's (EBR:MELE) Share Price Indicate?
Dec 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Nov 27Melexis (EBR:MELE) Knows How To Allocate Capital
Nov 15Calculating The Intrinsic Value Of Melexis NV (EBR:MELE)
Nov 03Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 10Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Sep 26Does Melexis (EBR:MELE) Have A Healthy Balance Sheet?
Sep 17Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Sep 02Melexis (EBR:MELE) Has Announced A Dividend Of €0.91
Aug 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Aug 05Melexis (EBR:MELE) Might Become A Compounding Machine
Jul 13Do Melexis' (EBR:MELE) Earnings Warrant Your Attention?
Jun 29Estimating The Intrinsic Value Of Melexis NV (EBR:MELE)
Jun 02At €99.75, Is Melexis NV (EBR:MELE) Worth Looking At Closely?
Apr 11With EPS Growth And More, Melexis (EBR:MELE) Makes An Interesting Case
Mar 27Is It Time To Consider Buying Melexis NV (EBR:MELE)?
Jan 09Here's Why Melexis (EBR:MELE) Has Caught The Eye Of Investors
Dec 24Is Melexis NV (EBR:MELE) Expensive For A Reason? A Look At Its Intrinsic Value
Nov 24Melexis (EBR:MELE) Is Paying Out A Dividend Of €0.91
Oct 18Melexis' (EBR:MELE) Dividend Will Be €0.91
Oct 04Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 20We Ran A Stock Scan For Earnings Growth And Melexis (EBR:MELE) Passed With Ease
Sep 19Melexis' (EBR:MELE) Dividend Will Be €0.91
Sep 05Melexis (EBR:MELE) Is Due To Pay A Dividend Of €0.91
Aug 22Melexis (EBR:MELE) Will Pay A Dividend Of €0.91
Aug 04Is There An Opportunity With Melexis NV's (EBR:MELE) 31% Undervaluation?
Jul 11Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Jun 27Does Melexis (EBR:MELE) Deserve A Spot On Your Watchlist?
Jun 13Should You Think About Buying Melexis NV (EBR:MELE) Now?
Mar 01Calculating The Fair Value Of Melexis NV (EBR:MELE)
Feb 14Melexis (EBR:MELE) Looks To Prolong Its Impressive Returns
Dec 06Should You Think About Buying Melexis NV (EBR:MELE) Now?
Nov 18Financial Position Analysis
Short Term Liabilities: MELE's short term assets (€474.5M) exceed its short term liabilities (€92.7M).
Long Term Liabilities: MELE's short term assets (€474.5M) exceed its long term liabilities (€199.4M).
Debt to Equity History and Analysis
Debt Level: MELE's net debt to equity ratio (25.3%) is considered satisfactory.
Reducing Debt: MELE's debt to equity ratio has increased from 18.4% to 31% over the past 5 years.
Debt Coverage: MELE's debt is well covered by operating cash flow (90.2%).
Interest Coverage: MELE's interest payments on its debt are well covered by EBIT (41.8x coverage).